September 15, 2021 — Revised guidelines for lung cancer screening eligibility are perpetuating disparities for racial/ethnic minorities, according to a new study in Radiology.

To get more flexibility and cost savings from storage, healthcare organizations are increasing their investments in the cloud

Healthcare organizations today are storing petabytes of medical imaging data — lab slides, X-rays, magnetic resonance imaging (MRI) scans, computed tomography (CT) scans and more — a number that is expanding with no end in sight.
Revenues for teleradiology reading service providers are forecast to follow a similar profile over this period.
Teleradiology read volumes dropped 22% in 2020, but rapid bounce back is already well underway

The closely tied relationship between teleradiology reading services and diagnostic imaging procedures resulted in an enormously challenging year for the teleradiology market. As healthcare providers’ resources became almost entirely focused on caring for those infected by the devastating COVID-19 virus, it contributed to the widespread global postponement of diagnostic imaging examinations.

September 15, 2021 — Siemens Healthineers announced the Food and Drug Administration (FDA) clearance of the SOMATOM X.ceed, a premium single-source computed tomography (CT) scanner that combines high-speed scanning capabilities and a level of resolution previously unseen in other single-source CT systems with a new h

Changing business models require the adoption of new technologies to remain efficient and effective

Does it take a global pandemic to change the way providers deliver care?
Cloud services have been utilized within healthcare organizations for more than a decade. Now with the growth of artificial intelligence (AI) it is very common to see organizations adopting cloud services.

Cloud solutions have been discussed and promoted within healthcare for more than 10 years. I recall the early 2010s seeing banners at conferences and marketing collateral raising the idea — which didn’t gather much momentum at the time.
Figure 1: MWT Schematic of a typical setup for detecting malignant tissues/tumors.
Figure 2: MWT Reconstructed Image: Results from single frequency reconstructions of the real (a-c) and imaginary (d-f) part of the complex permittivity for hemorrhagic stroke (left), 25% Ischemic stroke (middle) and 50% Ischemic stroke (right), using frequency hopping approach in frequency range of 0.7-1.5GHz and distorted Born iterative method, two-step iterative shrinkage thresholding DBIM-TwIST) image reconstruction algorithm.
Figure 3: Image of Per Vices SDR.

While microwave tomography (MWT) imaging has been around for a few decades, advances in computing power, artificial intelligence (AI)/machine learning algorithms and various imaging algorithms have brought a resurgence of interest in MWT.
As with all imaging technologies, COVID-19 is expected to continue to negatively impact the market.

According to a new report produced by Grand View Research, the global magnetic resonance imaging (MRI) market size was valued at $5.3 billion in 2020 and is expec
Evaluation of therapeutic efficacy of drug candidates in preclinical oncology with positron emission tomography (PET)
3-D PET/CT in situ detection of gastric tumors in mouse stomachs. Signals from 18F-FDG uptake in fasudil-treated (4 weeks) and control mice presented as graded color code with standard uptake value (SUVbw) range of 0.5-10. (Tu = tumor, bl =bladder). Arrows show the gastric tumor between the two kidneys and below the heart
PET/CT images of MDA-MB-231 tumor xenografts in mice 24 hours after intravenous injection with 64Cu-anti-hAXL. Treatment group received daily 17-AAG injections and showed lower tumor uptake of 64Cu-anti-hAXL than the vehicle-treated control group.

The use of positron emission tomography (PET) imaging in preclinical oncology investigations has shown the ability to determine the efficacy of potential novel treatments.

September 14, 2021 – Us2.ai, a Singapore-based medtech firm backed by Sequoia India and EDBI, has received U.S. Food and Drug Administration (FDA) clearance for Us2.v1, a completely automated decision support tool for echocardiography.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now